本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
SHANGHAI, Dec. 2, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that Department of Health of the Government of the Hong Kong Special Administrative Region, China, has accepted Everest's New Drug Application (NDA) for VELSIPITY® (etrasimod) for the treatment of adult patients with moderately to severely active ulcerative colitis. VELSIPITY® is an effective and convenient, once-daily, oral treatment for patients with moderately-to-severely active UC that has already been approved in the U.S. and E.U., and other countries, by Everest's licensing partner, Pfizer. In Everest territories, the Pharmaceutical Administration Bureau of the Macau Special Administrative Region, China has approved the NDA for VELSIPITY® in April of this year and was implemented in the Guangdong-Hong Kong-Macau Greater Bay Area this October through the "Hong Kong and Macau Medicine and Equipment Connect" policy. "Autoimmune disease is a core focus and a significant growth driver for our company. The number of UC patients in China is projected to double from 2019 to 2030 to approximately one million, highlighting the urgent need for novel treatments." said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. "Previously, VELSIPITY® has already been approved in Macau, China, and was implemented in the Greater Bay Area through the connect policy. The company also plans to submit the NDA for approval by China's National Medical Products Administration (NMPA) this year, with the aim of benefiting more Chinese patients as soon as possible." "This is an important advancement for etrasimod, bringing hope to patients in Hong Kong, China. This new-generation S1P receptor modulator is an oral, once-daily treatment that can provide patients with a chance for corticosteroid-free remission, mucosal healing, and rapid symptom relief, " said Prof. Wu Kaichun with the First Affiliated Hospital of AFMU who is the principal investigator for etrasimod's Asia clinical trial. "We hope China and other Asian countries can obtain approvals as soon as possible to benefit more patients." The acceptance of the NDA was based on results from the ELEVATE UC Phase 3 registrational program (ELEVATE UC 52 and ELEVATE UC 12) that evaluated the safety and efficacy of etrasimod 2 mg once-daily on clinical remission in UC patients with moderately to severely active UC who had previously failed or were intolerant to at least one conventional, biologic, or Janus kinase (JAK) inhibitor therapy. Nearly two-thirds of patients in ELEVATE UC 52 and ELEVATE UC 12 were naïve to biologic or JAK inhibitor therapy, and these studies were also the only studies for advanced therapies for ulcerative colitis to include patients with isolated proctitis. Both studies achieved all primary and key secondary efficacy endpoints, with a favorable safety profile consistent with previous studies of etrasimod. Everest conducted a multicenter, randomized, double-blind and placebo-controlled Phase 3 trial of etrasimod in Asian countries, including mainland China, China Taiwan and South Korea. This is the largest Phase 3 trial of moderately-to-severely active ulcerative colitis in Asia completed to date, with 340 eligible subjects randomized to treatment with etrasimod or placebo. The previously announced results of the induction period indicate that the clinical remission rate for patients treated with etrasimod 2mg was 25.0%, compared to 5.4% for those treated with placebo (difference 20.4%, p<0.0001). Compared to the placebo group, patients treated with etrasimod demonstrated significant clinical and statistically significant improvements in all key secondary endpoints. Subsequently, the topline results from maintenance period released in July of this year confirmed that after 40 weeks of treatment, etrasimod demonstrated significant clinical and statistical improvements over placebo in the primary and all key secondary endpoints (p<0.0001), and other secondary endpoints (including mucosal healing and endoscopic normalization, both p<0.0001). The safety profile of etrasimod was consistent with previous studies, with no new safety signals observed. The results of the maintenance period will be released at an international academic conference. About VELSIPITY® (etrasimod) VELSIPITY® is a once-daily, oral, sphingosine 1-phosphate (S1P) receptor modulator that selectively binds with S1P receptor subtypes 1, 4, and 5. Regulatory approvals have been granted in US, EU, Canada, Australia, Singapore, UK, Switzerland, Israel and Macau, China for VELSIPITY® in ulcerative colitis. About Everest Medicines Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality discovery, clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company's core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders. For more information, please visit its website at www.everestmedicines.com. Forward-Looking Statements: This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law.
KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 1 December 2024 - On December 1, the one-stop trendy retail brand OH!SOME opened its new store in Malaysia at Berjaya Times Square, Kuala Lumpur. During the grand opening event from December 1 to 8, new customers have the chance to win exclusive gifts such as Disney keychains, sleep masks, eye masks, and more. OH!SOME As a "Global Purchase" retail brand, OH!SOME offers over 10,000 selected products from around the world, including beauty and skincare products from China, Japan, and Korea, a wide range of global snacks and beverages, Japanese stationery, and popular Southeast Asian brands. OH!SOME has also established a long-term partnership with Disney, providing customers with a variety of merchandise featuring beloved Disney characters like Stitch, Donald Duck, and collections from Pixar. Notably, OH!SOME offers open-shelf trials for skincare and beauty products, allowing customers to try before they buy and eliminating the uncertainty of making blind purchases. Following its openings in Johor Bahru and Taiping, this will be OH!SOME's third store in Malaysia. So far, OH!SOME has already established nearly 80 stores in Indonesia. Moving forward, OH!SOME plans to open more stores in Malaysia and Singapore. Hashtag: #OH!SOMEThe issuer is solely responsible for the content of this announcement.
Conference highlights strategic initiatives aimed at bolstering the development of Western China's financial hub CHONGQING, China, Dec. 1, 2024 /PRNewswire/ -- The 5th Jiangbeizui New Financial Conference was held on November 28 at Chongqing Financial Convention and Exhibition Center, gathering over 500 participants from local government agencies, regulatory authorities and financial institutions. The conference focused on discussions and strategic planning for the development of the Western Financial Center. Jiangbei District is home to a quarter of the city's financial institutions. The district is a major player in the city's economy, with its financial sector accounting for one-fifth of both local and foreign currency deposits and loans. Jiangbei also leads in the number or listed companies and their market capitalization. Tao Shixiang, Secretary of Jiangbei District Party Committee, highlighted the district's leading economic performance, "Finance-led industries have fueled Jiangbei's rapid economic growth, with the district's GDP soaring 7.6% in the first three quarters, ranking first in the city." A key event at the conference was the signing of a memorandum of cooperation between the Institute of Directors (IoD) of the City of London and the Chongqing Jiangbeizui Central Business District Management Committee. Additionally, Zhou Hehua, Executive Deputy Director of Chongqing Municipal Financial Office and Director of the Chongqing Local Financial Supervision and Administration Bureau, unveiled the White Paper on the Development of the Western Financial Center (Chongqing). The Jiangbei District Government, in collaboration with the China Insurance Asset Registration and Trading System, Xinhua Finance Western Center, and several banks and insurance firms, launched the Insurance Funds Entry into Chongqing Service Platform. Two innovative projects were also unveiled: the Western Certified FinTech Training Base and the Joint Laboratory for Digital Government Innovative Applications. A report on the key performance indicators for the Upper Yangtze River was released during the ceremony, offering a detailed quantitative analysis of the river's expanding role as an inland shipping hub—a development greatly bolstered by the integration of rail-water intermodal transport.. The conference featured keynote speeches from a panel of distinguished financial leaders, including Xiao Gang, former Chairman of China Securities Regulatory Commission; Zhou Yanli, former Vice Chairman of China Insurance Regulatory Commission; John McLean, Chairman of the City of London IoD and Chairman of the China UK Business Development Centre, shared insights into London's evolution into one of the world's most important financial hubs.
What are the global health food trends? 'Botanical' and 'Energy' CERRITOS, Calif., Nov. 29, 2024 /PRNewswire/ -- Recently, JungKwanJang, a global comprehensive health brand and Korea's No. 1 red ginseng brand, added two new products to Sprouts Farmers Market: 'Everytime Immune Support' and 'Korean Red Ginseng Extract Vital Tonic'. 'Everytime Immune Support' is a stick-type red ginseng product that is good for boosting immunity, and it is a product developed for the US by focusing on 'Everytime' immunity. This product is mainly made up of Korean Red Ginseng, which helps boost immunity, and contains elderberry and pear concentrate, so you can take care of your health deliciously. JungKwanJang products at Sprouts Farmers Market 'Korean Red Ginseng Extract Vital Tonic' is a healthy energy shot product containing red ginseng and vitamins to improve metabolism and energy, and is popular as a steady seller for all age groups including 2030 in Korea. It is easy to carry and consume with its light ampoule formulation, so you can easily take care of your health anytime, anywhere. JungKwanJang will hold a discount promotion for popular JungKwanJang products on Amazon, direct stores, etc. from November 21 to December 2 to celebrate BFCM (Black Friday & Cyber Monday). 'HongSamWon', which has entered Costco, is receiving positive responses from consumers as a caffeine-free red ginseng functional drink, and the 'Everytime 2000mg' product is gaining popularity on Amazon. Meanwhile, at its R&D center in Fullerton near LA, JungKwanJang is working with local research teams to conduct scientific research on the efficacy and safety of key ingredients such as red ginseng and to develop new health ingredients. JungKwanJang ranked first in the global 'herbal health supplement' retail market compiled by Euromonitor International, a global market research firm, and ranked first in the 'global ginseng retail market' for 10 consecutive years, with a 46.6% share last year. Recently, plant-based natural ingredients are gaining popularity among consumers as their efficacy and safety are recognized. In fact, the global health food trends in 2024 are 'plant-based raw materials' and 'energy functionality'. According to Innova Market Insights in 2023, approximately 48% of US consumers believe that plant-based ingredients are effective. (*Innova Market Insights, February 2023, related article) Adaptogenic herbs such as 'ginseng' and 'ashwagandha' are also known to help maintain body balance. In particular, 'red ginseng' made from ginseng has been scientifically proven to have effects such as 'Boost Immune System', 'Building Stamina', and 'Support Blood Circulation'.(related article about Adaptogenic herbs 1, 2, 3 / related article about red ginseng 4) In fact, red ginseng has been officially recognized by the KFDA as helping to enhance immunity, improve blood circulation, improve fatigue, antioxidants, improve memory, menopausal women's health, and control blood sugar levels.(related article 1 - 66p, <Red Ginseng> 3) Prerequisite for the health functional food part, (1) Health Claim) (related article 2 – blood sugar) In addition, it has been scientifically proven by researchers at Georgia State University in the United States and Sungkyunkwan University in Korea that when red ginseng is consumed with vaccines, the effect of virus immunity is enhanced and immune cells are activated. (related article) Meanwhile, in July 2024, JungKwanJang launched three Asian best-selling 'Everytime' series products beyond Amazon to Sprouts Farmers Market. ("Everytime 2000mg," "Everytime Powerful Deer Antler," and "Everytime Energy Boost," under the concept of "Rev Your Energy Flow.")
HONG KONG, Nov. 29, 2024 /PRNewswire/ -- Today, CGI Global, the Chartered Governance Institute, the premier global qualifying body for Chartered Secretaries and Chartered Governance Professionals, announced the appointment of Kerrie Waring to lead the global institute as Director General. With nine divisions around the world and 29,000 members, the Chartered Governance Institute has actively promoted the highest standards of corporate governance for over 130 years. Ms Waring will report to the Council of CGI Global, working closely with Council Members and divisional CEOs, to promote the importance of Chartered Company Secretaries and Governance Professionals in supporting successful companies and long-term value creation, taking over from Tim Sheehy after he steps down on 30 November. CGI Global President, John Heaton said: "I am delighted that Kerrie is joining us, bringing great international experience of corporate governance over many years. She has long been an exponent of the value which good governance brings to organisations and is very well suited to developing the global strategy and expanding the reach and impact of CGI, building on Tim's work over the last 9 years. I am really looking forward to working with her." With over 25 years of corporate governance experience, Ms Waring joins CGI Global after serving as Chief Executive Officer of the International Corporate Governance Network for 10 years until June 2024. Prior to joining ICGN in 2008 as Chief Operating Officer, she was Corporate Governance Manager at the Institute of Chartered Accountants in England & Wales, and International Relations Manager at the UK Institute of Directors. A specialist in Japanese governance, Ms Waring served for seven years as a Member of the Council of Experts convened by the Tokyo Stock Exchange and Financial Services Agency to advise on governance and stewardship reforms. As Director General of CGI Global Ms Waring is responsible for strategically leading the profession's engagement with international stakeholders, expanding membership across markets, and driving scale and innovation across the industry's international qualifying scheme – the gold standard for governance professionals. Ms Waring said: "Chartered Secretaries and Governance Professionals are critical for supporting high-performing boards in their role to promote corporate sustainability and resilience, ultimately creating long-term value. They are the nexus between management, shareholders, auditors and others – ensuring timely information flows and the proper functioning of governance policies, procedures and practices. Based on the strong foundations established by my predecessor, I look forward to working with the CGI Council and Divisional CEOs in strategically leading CGI Global to its next phase and raising awareness of this important profession around the world." Ms Edith Shih FCG(CS, CGP) HKFCG(CS, CGP)(PE), CGI Global Past President, HKCGI Honorary Adviser and Past President, stated: "I am pleased that Kerrie is joining CGI as its Director General, bringing with her rich experience as a governance professional with international exposure in governance leadership." Ms Gillian Meller FCG HKFCG(PE), CGI Global Vice President and HKCGI Past President, said: "Kerrie is well suited to the role with her past experience and, importantly, her vision for CGI going forward. I look forward to working with her." About The Hong Kong Chartered Governance Institute(Incorporated in Hong Kong with limited liability by guarantee) The Hong Kong Chartered Governance Institute (HKCGI), formerly known as The Hong Kong Institute of Chartered Secretaries (HKICS), is the only qualifying institution in the Chinese mainland and Hong Kong for the internationally recognised Chartered Secretary and Chartered Governance Professional qualifications. With over 75 years of history and as the Hong Kong/China Division of The Chartered Governance Institute (CGI), the Institute's reach and professional recognition extends to all of CGI's nine divisions, with about 40,000 members and students worldwide. HKCGI is one of the fastest-growing divisions of CGI, having over 10,000 members, graduates and students with significant representations within listed companies and other cross-industry governance functions. Believing that better governance leads to better decisions for a better world, HKCGI's mission is to advance governance in commerce, industry, and public affairs through education, thought leadership, advocacy, and engagement with members and the broader community. As recognised thought leaders in our field, the Institute educates and advocates for the highest standards in governance and promotes an expansive approach that considers all stakeholders' interests. Better Governance. Better Future. For more information, please visit www.hkcgi.org.hk. © 2024 The Hong Kong Chartered Governance Institute. All rights reserved. Contact us HKCGI Marketing DepartmentTel: (852) 2881 6177Email: marketing@hkcgi.org.hk CGI GlobalEmail: cgioffice@mci-group.com
SINGAPORE - Media OutReach Newswire - 29 November 2024 - The "World of Opportunities: Russia-ASEAN" International Business Forum, held from November 26 to 27, officially concluded in Kuala Lumpur, the capital of Malaysia. Over two days, the Forum hosted more than 350 participants, including representatives from political, business, and academic circles, the media, as well as experts and public figures from 24 countries. Organized by the Roscongress Foundation, the event marked the first major initiative under the Roscongress International brand. (From left to right), Speakers of the ‘Russia and ASEAN’: Towards a New Stage of Trade and Economic Cooperation Plenary Session, Daniyar Akkaziev, Executive Director of the Russia–ASEAN Business Council, Airat Khairullin, Minister of Digital Development of Public Administration, Information Technology and Communications of the Republic of Tatarstan, Nazir Razak, Chairman of the ASEAN Business Advisory Council from Malaysia, Alexey Gruzdev, Deputy Minister of Industry and Trade of the Russian Federation, Oudet Suwannawong, President of the Lao Chamber of Commerce and Industry, Chairman of the ASEAN Business Advisory Council, Alexander Stuglev, Chairman of the Management Board, Director of the Roscongress Foundation and Abu Bakar Yusof, Deputy CEO of the Malaysia External Trade Development Corporation (MATRADE). "The 'Russia-ASEAN: World of Opportunities' Forum became one of the largest business events of its kind in the country and region in recent years, providing a unique platform to enhance trade relations between Russia and Southeast Asian countries. In 2023, Russia's trade turnover with ASEAN countries reached a record high, growing by 14.6% compared to the previous year. This positive trend continued in the first half of 2024, with a 20.5% increase. The business forum was a response to the growing interest of Russian businesses in ASEAN countries, particularly Malaysia, and further solidified Russia's strengthening trade position in Southeast Asia. I am confident that the Forum will serve as a significant discussion platform for addressing and broadly covering issues related to deepening trade and investment ties between Russia and ASEAN countries across various sectors," said Anton Kobyakov, Advisor to the President of the Russian Federation. The Forum's business agenda centered on trade and export interaction, energy, digital transformation, information security, technology, and innovations. Dedicated sessions also explored healthcare, tourism, education, and the impact of alumni communities in fostering international business connections. "Russia-Malaysia relations are dynamically progressing across a wide range of areas, providing optimism for their future. I believe this Forum served as an excellent starting point for creating and implementing new projects, fostering cooperation, and promoting open dialogue between the business community and government representatives. I hope the event's outcomes bring ASEAN countries and Malaysia closer to Russia, enabling the peoples of our nations to learn more about each other and explore new horizons for mutually beneficial relationships," emphasized Nail Latypov, the Ambassador Extraordinary and Plenipotentiary of Russia to Malaysia. He described Kuala Lumpur as a fitting choice for the event, noting that Malaysia will assume the ASEAN chairmanship in 2025 and highlighting the city's strategic location as a regional hub, within a two-hour flight of any ASEAN capital. The main highlight of the Forum was the plenary session, which featured participants such as Alexey Gruzdev, Deputy Minister of Industry and Trade of the Russian Federation; Ayrat Khayrullin, Minister of Digitalization of Public Administration, Information Technologies, and Communications of the Republic of Tatarstan; Tan Sri Nazir Razak, Founder and Chairman of Ikhlas Capital and Chairman of the ASEAN Business Advisory Council Malaysia; Oudet Souvannavong, President of the Lao National Chamber of Commerce and Industry and Chairman of the ASEAN Business Advisory Council; Alexander Stuglev, Chairman and CEO of the Roscongress Foundation; and Abu Bakar Yusof, Deputy Director of the Malaysia External Trade Development Corporation (MATRADE). Daniyar Akkaziev, Executive Director of the Russia-ASEAN Business Council, moderated the session. The business program on the first day continued with a panel discussion titled "The Energy Dimension of Strategic Partnership between Russia and ASEAN: Lessons Learned and New Directions" and the EAEU-ASEAN business dialogue. Discussions focused on exploring new formats of cooperation among businesses for sustainable, long-term development. The second day of the Forum featured panels on enhancing cooperation between Russia and Southeast Asian countries in digital transformation, healthcare, and medicine. Additional focus was given to strategies for increasing tourist flows and fostering educational partnerships. The "World of Opportunities: Russia-ASEAN" International Business Forum was held with the support of the Ministry of Industry and Trade of the Russian Federation and the Trade Representation of the Russian Federation in Malaysia. The Malaysia External Trade Development Corporation (MATRADE) served as the co-organizer. The Forum's general partner was the Tatarstan Trade House, while program partners included the Russia-ASEAN Business Council, the Eurasian Economic Commission, and Coalstar LLC. Hashtag: #RoscongressFoundation The issuer is solely responsible for the content of this announcement.About the Roscongress FoundationThe Roscongress Foundation is a socially oriented, non-financial development institution and the largest organizer of Russian, international, congress, exhibition, business, public, youth, sports, and cultural events. It was established in 2007 by presidential decree to promote economic potential, advance national interests, and strengthen Russia's image. The Foundation comprehensively studies, analyzes, and highlights issues on Russian and global economic agendas. It facilitates business project administration, investment promotion, social entrepreneurship, and charitable initiatives. Events organized by the Foundation attract participants from 209 countries and territories, with over 15,000 media representatives working at Roscongress venues annually. More than 5,000 experts from Russia and abroad are involved in its analytical and expert activities. The Foundation collaborates with UN structures and other international organizations, develops diverse partnerships with 212 foreign economic institutions, industrial and business associations, and financial and trade organizations in 86 countries. Domestically, it partners with 293 Russian public organizations and federal and regional executive and legislative bodies of the Russian Federation. Official Roscongress Telegram Channels: In Russian – t.me/Roscongress, in English – t.me/RoscongressDirect, in Spanish – t.me/RoscongressEsp, and in Arabic – t.me/RosCongressArabic. Official website and information-analytical system: roscongress.org.
A12 藝術空間
new
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
